Back to Search
Start Over
Dosimetric Comparison Between Proton and Photon Radiation Therapies for Pediatric Neuroblastoma.
- Source :
-
International journal of particle therapy [Int J Part Ther] 2024 May 22; Vol. 12, pp. 100100. Date of Electronic Publication: 2024 May 22 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- Purpose: The aim of this study is to determine the most beneficial radiation treatment technique for pediatric patients with thoracic and abdominal neuroblastoma (NBL), through a dosimetric comparison between photon Volumetric Modulated Arc Therapy and proton Intensity-Modulated Proton Therapy treatment plans.<br />Materials and Methods: A retrospective analysis was conducted on a multicentre case series of 19 patients with thoracic and/or abdominal NBL who underwent radiation therapy, following the recommendations of the European protocol for high-risk NBL (HR-NBL2/SIOPEN). The prescribed dose was 21.6 Gy in 12 fractions (1.8 Gy/fraction) delivered over the preoperative disease volume. The dose volume histograms were analyzed for each patient, and a Wilcoxon signed-rank test with a significance level of 0.01 was employed to assess statistical differences between the dosimetric parameters investigated. Two homogeneity indices (HI and <subscript>new</subscript> HI) were compared to evaluate the uniformity in dose, delivered to the adjacent vertebrae (VBs&#95;Adj).<br />Results: Both radiation techniques conform to the protocol regarding CTV/PTV coverage for every location. Proton therapy resulted in statistically significant dose sparing for the heart and lungs in supradiaphragmatic locations and for the contralateral kidney, liver, spleen, and bowel in subdiaphragmatic locations. For both techniques, sparing the non-adjacent vertebrae (VBs&#95;NAdj) results more challenging, although promising results were obtained. Furthermore, the dose delivered to the VBs&#95;Adj was not statistically different, in terms of homogeneity, for the 2 radiation techniques that both met the protocol's requirements.<br />Conclusion: This dosimetric analysis highlights the potential of protons to reduce radiation dose to healthy tissue. These findings apply to all the investigated patients, regardless of primary tumor location, making proton therapy a valuable option for the treatment of neuroblastoma. However, a multidisciplinary assessment of each case is essential to ensure the selection of the most effective and suitable treatment modality.<br />Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Alfredo Mirandola reports administrative support, article publishing charges, equipment, drugs, or supplies, statistical analysis, travel, and writing assistance were provided by National Centre of Oncological Hadrontherapy. Alfredo Mirandola reports a relationship with the National Centre of Oncological Hadrontherapy that includes: employment. Alfredo Mirandola has patent issued to no. Nothing to add If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2024 The Authors.)
Details
- Language :
- English
- ISSN :
- 2331-5180
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- International journal of particle therapy
- Publication Type :
- Academic Journal
- Accession number :
- 39022120
- Full Text :
- https://doi.org/10.1016/j.ijpt.2024.100100